CRISPR-Cas systems may also help reduce the leading cause of death in diseases, such as Duchenne muscular dystrophy (DMD), which is a progressive genetic disease that causes muscle degeneration and weakness by altering the protein dystrophin, this protein is responsible for keeping the muscle cells intact [109]. This evidence concerns the gene DMD and Duchenne muscular dystrophy.